DGNOFDiagnos Inc.

About Diagnos Inc. (DGNOF)

Diagnos Inc. (DGNOF) is a Health Information Services company headquartered in Brossard, QC, Canada whose shares trade over-the-counter on the OTCQB tier.

DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems through the use of its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (POC). CARA image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for screening large numbers of patients in real-time.

Products and services

DIAGNOS markets CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care. CARA’s image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible.

DGNOF key facts

Ticker symbol

DGNOF

Market tier

OTCQB

Sector

Healthcare

Industry

Health Information Services

Headquarters

Brossard, QC, Canada

Country of incorporation

CA

Year of incorporation

1996

Employees

15

Estimated market cap

$19.44M (as of Apr 10, 2025)

Shares outstanding

101,862,977

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

3/31

Latest filing

Interim Financial Report (Dec 31, 2024)

Diagnos Inc. leadership

• Andre Larente — President
• Yves-Stephane Couture — COO
• Marc-Andre Massue — CFO
• Cindy Mercier — Contact Person

Explore more: Health Information Services stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with D